Boston Common Asset Management Upped Biogen Com (BIIB) Holding By $457,919; PC Connection (CNXN) Shorts Lowered By 0.07%

January 14, 2018 - By Richard Conner

PC Connection Incorporated (NASDAQ:CNXN) had a decrease of 0.07% in short interest. CNXN’s SI was 420,800 shares in January as released by FINRA. Its down 0.07% from 421,100 shares previously. With 33,800 avg volume, 12 days are for PC Connection Incorporated (NASDAQ:CNXN)’s short sellers to cover CNXN’s short positions. The SI to PC Connection Incorporated’s float is 3.67%. The stock increased 0.19% or $0.05 during the last trading session, reaching $27.01. About 20,960 shares traded. PC Connection, Inc. (NASDAQ:CNXN) has risen 18.98% since January 14, 2017 and is uptrending. It has outperformed by 2.28% the S&P500.

Boston Common Asset Management Llc increased Biogen Inc Com (BIIB) stake by 5.38% reported in 2017Q3 SEC filing. Boston Common Asset Management Llc acquired 1,463 shares as Biogen Inc Com (BIIB)’s stock declined 13.45%. The Boston Common Asset Management Llc holds 28,656 shares with $8.97M value, up from 27,193 last quarter. Biogen Inc Com now has $71.05B valuation. The stock increased 0.86% or $2.88 during the last trading session, reaching $335.95. About 885,516 shares traded. Biogen Inc. (NASDAQ:BIIB) has risen 4.94% since January 14, 2017 and is uptrending. It has underperformed by 11.76% the S&P500.

PC Connection, Inc., together with its subsidiaries, provides a range of information technology solutions. The company has market cap of $724.29 million. The firm operates through three divisions: SMB, Large Account, and Public Sector. It has a 15.43 P/E ratio. It offers IT products, such as computer systems, software and peripheral equipment, networking communications, and other products and accessories.

Among 31 analysts covering Biogen Idec Inc. (NASDAQ:BIIB), 22 have Buy rating, 0 Sell and 9 Hold. Therefore 71% are positive. Biogen Idec Inc. had 95 analyst reports since July 23, 2015 according to SRatingsIntel. The stock has “Hold” rating by Jefferies on Tuesday, July 11. The firm has “Buy” rating given on Wednesday, November 8 by Oppenheimer. The stock has “Buy” rating by Cowen & Co on Tuesday, August 25. The stock of Biogen Inc. (NASDAQ:BIIB) has “Hold” rating given on Monday, June 12 by Jefferies. PiperJaffray reinitiated Biogen Inc. (NASDAQ:BIIB) on Monday, October 23 with “Overweight” rating. The company was maintained on Wednesday, October 25 by RBC Capital Markets. BMO Capital Markets maintained Biogen Inc. (NASDAQ:BIIB) on Monday, November 27 with “Buy” rating. The firm has “Hold” rating by Jefferies given on Wednesday, October 5. The firm has “Buy” rating given on Monday, October 23 by Guggenheim. On Monday, November 7 the stock rating was upgraded by Leerink Swann to “Outperform”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: